Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
1 clinical trials · Condition
◉ Watch Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer (NCT03294694) | Dana-Farber Cancer Institute | 2017-11-08 |
Track Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.